Literature DB >> 19806259

Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty.

Gerhard J Johnson1, Linda A Leis, Ronald R Bach.   

Abstract

Tissue factor (TF) is present in small quantities in normal blood and is reported to be elevated in arterial and venous thrombosis. Patients undergoing total knee arthoplasty (TKA) are at high risk of post-operative venous thromboembolism (VTE). To evaluate the possible contribution of elevated blood TF to VTE risk, we performed serial studies of peripheral blood mononuclear cell (PBMC) functional TF procoagulant activity (PCA) in 19 patients after TKA. PBMC and platelet TF PCA were measured by a functional, clot-based assay following decryption with a calcium ionophore. Plasma TF antigen levels were measured by ELISA. All subjects received chemoprophylaxis and none had VTE. After TKA total TF PCA of PBMC was elevated in 19 of 19 subjects. The peak increase above preoperative levels was 1.1-13.6 fold (>two-fold in 58% and >three-fold in 42%). Median TF PCA of PBMC was not elevated following tourniquet removal, but it was significantly elevated on postoperative days 1 and 2. Thereafter, it decreased to near preoperative values at day 6. Neither platelet TF PCA nor plasma TF antigen levels increased significantly. Since the PBMC count did not rise, the increase in TF PCA was attributable to cell synthesis. The increase in blood TF PCA preceded the median time of diagnosis of venous thromboembolism after TKA established previously. These observations indicate a) TKA stimulates synthesis of encrypted PBMC TF PCA which is likely to contribute to the pathophysiology of VTE; b) TF antigen is not a reliable indicator of TF PCA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806259     DOI: 10.1160/TH09-04-0261

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

Review 1.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

2.  Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.

Authors:  B N Yamaja Setty; Nigel S Key; A Koneti Rao; Suhita Gayen-Betal; Suba Krishnan; Carlton D Dampier; Marie J Stuart
Journal:  Br J Haematol       Date:  2012-02-24       Impact factor: 6.998

Review 3.  Microparticles in hemostasis and thrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

4.  Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.

Authors:  Jeffrey I Weitz; Rupert Bauersachs; Bastian Becker; Scott D Berkowitz; Maria C S Freitas; Michael R Lassen; Carola Metzig; Gary E Raskob
Journal:  JAMA       Date:  2020-01-14       Impact factor: 56.272

Review 5.  Analysis of tissue factor positive microparticles.

Authors:  Nigel S Key
Journal:  Thromb Res       Date:  2010-02-26       Impact factor: 3.944

Review 6.  Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

Review 7.  Role of tissue factor in venous thrombosis.

Authors:  David A Manly; Jeremiah Boles; Nigel Mackman
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

8.  New insights into the mechanisms of venous thrombosis.

Authors:  Nigel Mackman
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

Review 9.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

10.  Coagulation activation in sickle cell trait: an exploratory study.

Authors:  Chirag Amin; Soheir Adam; Micah J Mooberry; Abdullah Kutlar; Ferdane Kutlar; Denise Esserman; Julia E Brittain; Kenneth I Ataga; Jen-Yea Chang; Alisa S Wolberg; Nigel S Key
Journal:  Br J Haematol       Date:  2015-09-07       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.